Search Results for 'diabetes mellitus'

Boots Pharmacy Athlone are delighted to be offering a Winter Flu Vaccination Service.

REMEDI, The Regenerative Medicine Institute at NUI Galway and Orbsen Therapeutics have entered into an agreement with Cardium Therapeutics to utilise Cardium’s Excellagen® pharmaceutically-formulated gel as a delivery agent for Orbsen Therapeutics’ proprietary stromal cell therapy in pre-clinical studies for the potential treatment of diabetic foot ulcers.

NUI Galway has been awarded a major new €6 million European project, designed to address complications associated with diabetes. The research project will examine the ability of stem cells to safely control glucose levels and alleviate the damage caused by six different diabetic complications.

Director of REMEDI, Professor Timothy O’Brien, is Head of Medicine at NUI Galway and a consultant endocrinologist at Galway University Hospital. REMEDI is one of Ireland’s top biomedical research institutes.

In a major boost for regenerative medicine research in Ireland, Minister for Enterprise, Trade, and Innovation, Batt O’Keeffe announced this week the funding of almost €10 million for the Regenerative Medicine Institute (REMEDI) at NUI Galway.

NUI Galway and the University of Ulster have joined forces with HSE West and the Western Health and Social Care Trust to create a collaborative cross-border partnership on diabetes-related research.